Ian is a professional with over 35 years of extensive experience in international business. Born and educated in Cape Town, South Africa, his career has been characterized by an emphasis on business and corporate development, access to capital, and finance. Ian has established himself as a pivotal figure in fostering strategic financial partnerships and international relations, aiding numerous companies in accessing global opportunities.
Since 2010 Ian had been an Operating Partner with the Bridgewest Group, a private investment firm with global investments in innovative software, semiconductor, life sciences and biotech and is a co-investor in several life science portfolio Companies including BioDuro, BioCina, BioArdis and Bio4t2.
Since exiting the full-time operational role at BioCina and Bridgewest, Ian has begun offering support to companies in Australia by leveraging his experience and extensive relationships in the life sciences industry in the USA, Europe and Asia.
Ian’s career is marked by his adeptness at forging strategic financial partnerships with a wide array of institutions. His ability to connect local, national, and international organizations has been a cornerstone of his professional journey. Additionally, Ian has excelled in fostering international relations with both government agencies and private institutions, further amplifying his impact in the global business arena. He has an investor network encompassing Australia, New Zealand, Asia, EU and USA.
Ian is Executive Director of Triovance Holdings, LLC, a biotech company based in San Diego, NED with Clever Culture Systems (ASX:CC5), NED with PsyBio and an Advisor to Sementis, a vaccinia platform company and BiomeBank, a microbiome platform company, both based in Adelaide, Australia.